Gene Query: MRPL42

Dataset Description Geneva Score
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 43.93
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 42.23
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 36.63
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 28.91
hnRNP C is a key regulator of protein synthesis in mitosis 27.16
Region-specific Innate Antiviral Responses of the Human Epididymis 26.16
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 25.4
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 25.31
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 22.41
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 22.3
Human cell line and subcutaneous tumor 21.23
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 20.82
Sensing self and nonself circular RNAs 20.17
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 19.54
RIG-I and MDA5 fRIP during KSHV lytic reactivation 19.5
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 18.68
Role of XRN2 ribonucleolytic activity in RNA metabolism 18.31
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 17.95
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 17.55
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 17.4
Altering cancer transcriptomes using epigenomic inhibitors 17.4
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 17.37
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 17.01
ETV7 and interferon response 17.01
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 16.91
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 16.72
HNRNPL and its RNA Targets in Prostate Cancer 16.72
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 16.42
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 16.24
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 16.24
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 15.64
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 15.47
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 15.43
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 15.26
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 15.26
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 14.89
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 14.35
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 14.28
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 14.27
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 14.08
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 14.08
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.99
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 13.93
Mapping interactions for the TNIP2 hub protein 13.77
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 13.72
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.7
Determination of tRNA aminoacylation levels by high throughput sequencing 13.52
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 13.29
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 13.17
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 13.03
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 12.84
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 12.84
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 12.8
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 12.8
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 12.77
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 12.64
Global expression profiles in cardiac progenitor cells generated by ISX-9 12.64
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.55
Regulation of protein translation during mitosis 12.46
Tracking of dCas9-methyltransferase footprints 12.43
MYC dependent mRNA translation shapes gene expression and cell biology 12.42
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 12.37
Gene expression changes after LOC550643 silencing 12.29
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 12.11
HEXIM1 is induced by DHODH inhibition to suppress melanoma 12.03
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 12.03
Single-nucleotide-resolution mapping of HBV promoters using CAGE 11.85
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 11.58
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 11.16
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 11.14
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 11.14
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 11.14
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.09
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 11.01
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.96
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 10.95
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 10.9
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.82
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 10.71
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.71
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.7
Effect of mitochondria deficiency on senescence-associated gene expression 10.63
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 10.57
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.49
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.49
RNAseq of HEK293 cells after Chtop knockdown 10.41
Co-transcriptional loading of RNA export factors shapes the human transcriptome 10.41
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 10.27
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.27
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 10.21
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.18
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.18
Profiling of escape kinetics of viruses subjected to RNAi 10.18
Transcriptome analysis upon C6orf203 silencing 10.12
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 10.12
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 10.04
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 10.04
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.91
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.91
Transcriptome analysis of Zika infected neural stem cells 9.91
Zika infected neural stem cells 9.91
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 9.87
3’ Uridylation Expands miRNA Target Repertoire 9.86
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.8
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 9.72
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.66
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.62
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.6
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.6
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 9.49
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 9.49
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 9.37
Solid phase chemistry to covalently and reversibly capture thiolated RNA 9.17
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 9.15
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 9.15
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.1
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 9.09
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 9.08
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.04
An RNA-centric dissection of host complexes controlling flavivirus infection 9.03
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.03
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.0
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 9.0
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.95
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.93
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.93
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 8.86
RNA transcriptome analysis during HSV-1 infection 8.84
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 8.84
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 8.84
Lipid degradation promotes prostate cancer cell survival 8.82
RNA polymerase in pre-B-ALL cell lines 8.82
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 8.78
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 8.78
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 8.73
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.67
A prostate cancer chromatin interaction map 8.66
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 8.62
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 8.62
CROP-Seq in Primary Human T Cells 8.6
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.5
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 8.48
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 8.41
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 8.41
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 8.41
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 8.41
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 8.36
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 8.34
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.33
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 8.29
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 8.29
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 8.27
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 8.26
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.15
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.15
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.13
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.13
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 8.07
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.07
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.07
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 8.06
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.05
Global analysis of alternative splicing regulated by RBM10 8.04
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 7.98
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.97
CD73 knockdown effect in pancreatic cancer cell lines 7.94
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.89
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 7.84
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 7.84
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.82
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.82
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.82
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 7.79
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.78
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.78
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 7.76
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.75
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.75
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 7.73
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.66
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.64
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.64
TGF-β regulation of miRNA expression in pancreatic cancer 7.63
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 7.59
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.59
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 7.55
H1609088 Human RNA-Sequencing 7.54
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 7.52
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 7.52
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.51
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.49
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.49
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 7.49
Human neutrophil genome during PMA- and E. coli encounter-induced activation 7.47
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 7.47
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 7.46
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 7.46
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.43
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.42
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.41
Patient-derived luminal breast cancer xenografts with progestins 7.41
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.4
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.35
mRNA expression profile of Lymphocytes 7.34
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.32
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.29
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 7.21
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 7.21
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 7.12
Transcriptome profiling of Normal and Cancerous Prostate Cells 7.12
The landscape of alternative splicing in aggressive prostate cancers 7.06
RNA-seq of RKO cells with cTAZ KO or putback 7.02
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 7.0
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 7.0
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.99
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.92
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 6.9
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 6.9
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.89
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 6.89
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 6.87
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.85
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 6.84
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.81
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.71
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.7
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.7
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.69
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.69
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.67
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 6.63
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.61
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 6.61
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.55
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.55
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.52
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.41
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 6.41
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 6.41
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.38
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.38
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.29
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 6.28
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.26
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.26
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.22
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.21
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 6.17
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.12
Effect of ILF3 on translation during homeostasis and the antiviral response 6.11
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 6.08
Global analysis of enhancer targets: Mosaic-seq 6.07
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 6.06
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.06
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.99
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.99
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 5.95
IDH3a KO RNA-seq 5.94
The age and genomic integrity of neurons after cortical stroke in humans 5.93
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 5.93
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 5.89
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 5.84
The Genetic Landscape of Diamond-Blackfan Anemia 5.83
Comparative Analysis of Cas9 Activators Across Multiple Species 5.78
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.7
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 5.66
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.64
Capturing the Interactome of Newly Transcribed RNA 5.64
Trans-differentiation of human adult peripheral blood T cells into neurons 5.63
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 5.58
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.58
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 5.51
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.5
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.49
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.49
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.48
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 5.47
SLIGRL-induced gene expression changes in NHEK cells 5.43
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.36
Triple vectors expand AAV transfer capacity in the retina 5.32
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.25
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.23
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.22
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.19
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.18
RNA-seq of IL-4 stimulated human keratinocytes 5.16
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.15
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.14
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.14
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 5.14
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 5.14
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.13
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.08
STX4 Over-Expression in Human islets 5.07
Gene expression profiling of leukemia cells following asparagine depletion 5.07
Human HAP1 cells before and after nutrient deprivation 5.05
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.97
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.93
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.93
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.93
RNA sequencing of primary human platelets and in vitro cell lines 4.93
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.92
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 4.88
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.78
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.69
Co-regulation of splicing by Rbfox1 and hnRNP M 4.69
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.67
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 4.6
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 4.6
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.56
Targeting EZH2 in MYCN-amplified Neuroblastoma 4.56
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 4.56
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.54
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.53
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.53
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.53
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 4.46
Molecular Criteria for Defining the Naive Human Pluripotent State 4.43
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 4.43
O-glcnAc reprograms cellular energetics 4.39
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.36
RNA expression analysis upon JMJD1C depletion 4.36
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.34
TOP2B disturbed the quality of human oocytes with advanced maternal age 4.32
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.3
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.3
Transcriptome of diurnal human blood neutrophils 4.29
K562 polyA RNA-Seq 4.23
RNA sequencing of human mammary epithelial cells 4.22
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.21
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 4.2
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.2
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.18
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 4.17
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.16
Enhancer activation during EGF response 4.11
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.09
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.05
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.91
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.85
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.83
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.83
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 3.65
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.63
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.46
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.42
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.42
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.34
Gene expression profile in breast cancer cells 3.34
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 3.3
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 3.3
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.25
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.25
RNA-Seq of PRMT1 overexpression ECA109 cells 3.25
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.22
In vitro modeling of human germ cell development using pluripotent stem cells 3.19
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.13
Role of COP1 on MAP kinase transcriptional output in melanoma 3.13
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.07
Interaction between mitoNEET and NAF-1 in cancer cells 3.04
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.99
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.99
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.97
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.95
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.9
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.88
Effect of PRDM11 depletion in U2932 cells 2.88
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.86
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.79
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.79
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 2.78
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.72
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.69
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 2.67
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.67
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.6
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.58
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.56
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.55
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.49
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.45
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.45
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.44
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.44
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 2.43
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.37
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.36
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.36
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.29
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.27
DRB/GRO-Seq -/+ UV 2.24
The contribution of Alu exons to the human proteome 2.19
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.15
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.15
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.11
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.11
MicroRNA-125a-5p overexpression in human macrophages 2.06
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.06
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 2.01
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.97
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.95
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.95
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.95
Myc activation coordinates gene transcription and protein translation responses 1.92
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.9
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.79
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.78
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.76
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.76
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.75
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.68
High-resolution comparative analysis of great ape genomes 1.62
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.58
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.53
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.52
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.52
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.44
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.44
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.42
HBEC-shp53-PCHD7 1.41
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.39
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.36
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.36
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.33
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.27
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.25
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 1.22
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.19
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.19
Transcriptomic analysis of LSD1 1.17
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.13
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 1.13
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.13
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.09
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.08
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.06
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.0
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.95
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.95
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.94
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.94
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.93
SF3B1 Degron knockdown RNA-seq 0.91
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.89
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.89
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.87
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.84
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.84
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.84
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.83
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.83
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.81
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.72
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.71
Modulation of nonsense-mediated decay by rapamycin 0.68
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.67
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.66
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.62
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.59
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.56
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.51
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.51
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.5
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.5
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.48
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.47
Expression profiling of MCF-7 cells with treatment of TCDD 0.46
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.46
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.46
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.45
Regulation of hypoxia-inducible factor activity by ZMYND8 0.44
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.42
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.42
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.4
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.38
A single-cell transcriptome atlas of the human pancreas 0.37
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.34
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.28
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.28
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.28
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.26
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.25
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.24
iPSC derived motor neuron cultures from C9ORF72 carriers 0.22
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.2
circRNA-sequencing 0.16
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.14
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.14
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.13
Human Tfh cell RNA bulk sequencing 0.11
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 0.11
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.07
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.05
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.0
Interphase condensins regulate ligand-depedent enhancer activation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation